| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72eabed977dec5875ae377b1b2fdad35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 |
| filingDate |
2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725eaf7a0189fcdf1ed356c8c4747aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499c7e4a180db0e9a9102101f80fcfa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68bc851311521f4803f293c3fcf8987e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c0c9d9b48af24b090e4da6a825f5f05 |
| publicationDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012250999-A |
| titleOfInvention |
Novel anti-arrhythmic and heart failure drugs and their use targeting ryanodine receptor (RyR2) leakage |
| abstract |
A method for limiting or preventing a decrease in RyR2-bound FKBP12.6 levels in a patient suffering from or a candidate for atrial fibrillation. A method of limiting or preventing a decrease in RyR2-bound FKBP12.6 levels in a patient suffering from or a candidate for atrial fibrillation, wherein the level of RyR2-bound FKBP12.6 in the patient is Administering to the patient an amount of JTV-519 effective to limit or prevent reduction, wherein the RyR2 is atrial RyR2. [Selection figure] None |
| priorityDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |